Drug update

Drospirenone 4mg: a new progestogen-only pill

Drug update

Drospirenone 4mg: a new progestogen-only pill

Deborah Bateson, Kathleen McNamee

Figures

© andrew chekasov/ stock.adobe.com
© andrew chekasov/ stock.adobe.com

Abstract

The drospirenone progestogen-only pill became available in Australia in August 2021. With similar efficacy to combined oral contraceptives, it offers another option for those who prefer an oral method and need or desire a method without oestrogen.

Article Extract

Aprogestogen-only pill (POP) that inhibits ovulation and has a similar efficacy to combined oral contraceptives (COCs) became available in Australia in August 2021. The new POP contains drospirenone 4 mg in a 24/4 regimen. It has many of the advantages of the traditional levonorgestrel 30 mcg and norethisterone 350 mcg POPs (‘mini-pills’) but has been developed to avoid some of their disadvantages. Practice points on the drospirenone POP are summarised in the Box.